Found: 90
Select item for more details and to access through your institution.
Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis.
- Published in:
- Journal of Cutaneous Pathology, 1997, v. 24, n. 9, p. 553, doi. 10.1111/j.1600-0560.1997.tb01459.x
- By:
- Publication type:
- Article
The Usefulness of Atopic Dermatitis Control Tool in Upadacitinib Treatment for Patients with Atopic Dermatitis.
- Published in:
- Dermatologic Therapy, 2024, v. 2024, p. 1, doi. 10.1155/2024/4115539
- By:
- Publication type:
- Article
Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 4, p. 996, doi. 10.1002/eji.200838852
- By:
- Publication type:
- Article
IL-12, IL-23, and IL-27 enhance human β-defensin-2 production in human keratinocytes.
- Published in:
- European Journal of Immunology, 2008, v. 38, n. 5, p. 1287, doi. 10.1002/eji.200738051
- By:
- Publication type:
- Article
IL-18 enhances IFN-γ-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
- Published in:
- European Journal of Immunology, 2007, v. 37, n. 2, p. 338, doi. 10.1002/eji.200636420
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single‐center retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 5, p. 649, doi. 10.1111/1346-8138.17186
- By:
- Publication type:
- Article
Dietary habits in adult Japanese patients with vitiligo.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 4, p. 491, doi. 10.1111/1346-8138.17163
- By:
- Publication type:
- Article
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 12, p. 1576, doi. 10.1111/1346-8138.16950
- By:
- Publication type:
- Article
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. 1301, doi. 10.1111/1346-8138.16879
- By:
- Publication type:
- Article
Two cases of generalized pustular psoriasis successfully treated with bimekizumab.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. e357, doi. 10.1111/1346-8138.16866
- By:
- Publication type:
- Article
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 7, p. 869, doi. 10.1111/1346-8138.16763
- By:
- Publication type:
- Article
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 11, p. 1158, doi. 10.1111/1346-8138.16549
- By:
- Publication type:
- Article
Two novel mutations in the ATP2C1 gene found in Japanese patients with Hailey–Hailey disease.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 6, p. 656, doi. 10.1111/1346-8138.16353
- By:
- Publication type:
- Article
Real‐world blood examination screening data before initiation of biologics for psoriasis patients.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 5, p. 534, doi. 10.1111/1346-8138.16333
- By:
- Publication type:
- Article
Generalized pustular psoriasis with deficiency of interleukin‐36 receptor antagonist associated with sensorineural hearing impairment.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 9, p. e470, doi. 10.1111/1346-8138.16023
- By:
- Publication type:
- Article
Generalized pustular psoriasis complicated with idiopathic retroperitoneal fibrosis successfully treated with infliximab.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 9, p. e436, doi. 10.1111/1346-8138.15974
- By:
- Publication type:
- Article
Serum interleukin‐10 level increases in patients with severe signs or symptoms of herpes zoster and predicts the duration of neuralgia.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 4, p. 511, doi. 10.1111/1346-8138.15818
- By:
- Publication type:
- Article
Dietary habits in Japanese patients with palmoplantar pustulosis.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 3, p. 366, doi. 10.1111/1346-8138.15719
- By:
- Publication type:
- Article
Severe atopic dermatitis effectively treated with dupilumab changed from interleukin‐5 inhibitors for concomitant severe bronchial asthma.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 2, p. e76, doi. 10.1111/1346-8138.15691
- By:
- Publication type:
- Article
Case of subcorneal pustular dermatosis during carfilzomib treatment for immunoglobulin G κ multiple myeloma.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 1, p. e37, doi. 10.1111/1346-8138.15622
- By:
- Publication type:
- Article
Case of Hailey‐Hailey disease with a novel missense/in‐frame deletion mutation in ATP2C1 successfully treated with cyclosporine.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 12, p. e482, doi. 10.1111/1346-8138.15081
- By:
- Publication type:
- Article
Dietary habits in Japanese patients with psoriasis and psoriatic arthritis: Low intake of meat in psoriasis and high intake of vitamin A in psoriatic arthritis.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 9, p. 759, doi. 10.1111/1346-8138.15032
- By:
- Publication type:
- Article
Case of alopecia areata during dupilumab treatment for atopic dermatitis.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 9, p. e332, doi. 10.1111/1346-8138.14880
- By:
- Publication type:
- Article
Dietary habits in adult Japanese patients with atopic dermatitis.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 6, p. 515, doi. 10.1111/1346-8138.14881
- By:
- Publication type:
- Article
Treatment with apremilast was beneficial for chronic graft‐versus‐host disease skin lesion in a patient with psoriasis.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 6, p. e218, doi. 10.1111/1346-8138.14766
- By:
- Publication type:
- Article
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 6, p. e219, doi. 10.1111/1346-8138.14728
- By:
- Publication type:
- Article
Severe myalgia associated with brodalumab treatment in a patient with psoriasis.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 12, p. e327, doi. 10.1111/1346-8138.14474
- By:
- Publication type:
- Article
Two cases of skin infection during psoriasis treatment with brodalumab.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 3, p. e51, doi. 10.1111/1346-8138.14119
- By:
- Publication type:
- Article
Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
- Published in:
- Journal of Dermatology, 2016, v. 43, n. 7, p. 785, doi. 10.1111/1346-8138.13227
- By:
- Publication type:
- Article
Immunoresponses in dermatomycoses.
- Published in:
- Journal of Dermatology, 2015, v. 42, n. 3, p. 236, doi. 10.1111/1346-8138.12718
- By:
- Publication type:
- Article
Antimycotics suppress the Malassezia extract-induced production of CXC chemokine ligand 10 in human keratinocytes.
- Published in:
- Journal of Dermatology, 2014, v. 41, n. 2, p. 124, doi. 10.1111/1346-8138.12380
- By:
- Publication type:
- Article
Narrow Histopathological Margins are Acceptable in Surgical Resection of Basal Cell Carcinoma in Japanese: A Single-Center Retrospective Study.
- Published in:
- Journal of Nippon Medical School, 2024, v. 91, n. 3, p. 296, doi. 10.1272/jnms.JNMS.2024_91-308
- By:
- Publication type:
- Article
Active Tuberculosis in a Patient Receiving Adalimumab for Psoriatic Arthritis and Chemoprophylaxis for Latent Tuberculosis Infection.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2023, v. 90, n. 2, p. 194, doi. 10.1272/jnms.JNMS.2023_90-207
- By:
- Publication type:
- Article
Change in Antinuclear Antibody Titers during Biologic Treatment for Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2023, v. 90, n. 1, p. 96, doi. 10.1272/jnms.JNMS.2023_90-115
- By:
- Publication type:
- Article
Association of Transition of Laboratory Markers with Transition of Disease Activity in Psoriasis Patients Treated with Biologics.
- Published in:
- Journal of Nippon Medical School, 2022, v. 89, n. 6, p. 587, doi. 10.1272/jnms.JNMS.2022_89-613
- By:
- Publication type:
- Article
A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2021, v. 88, n. 6, p. 569, doi. 10.1272/jnms.JNMS.2021_88-517
- By:
- Publication type:
- Article
Nutrition and Atopic Dermatitis.
- Published in:
- Journal of Nippon Medical School, 2021, v. 88, n. 3, p. 171, doi. 10.1272/jnms.JNMS.2021_88-317
- By:
- Publication type:
- Article
A Case of Autoimmune Hepatitis during Brodalumab Treatment for Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2020, v. 87, n. 6, p. 359, doi. 10.1272/jnms.JNMS.2020_87-607
- By:
- Publication type:
- Article
Lupus Erythematosus Tumidus with Pseudolymphomatous Infiltrates: A Case Report.
- Published in:
- Journal of Nippon Medical School, 2020, v. 87, n. 2, p. 100, doi. 10.1272/jnms.JNMS.2020_87-208
- By:
- Publication type:
- Article
Atopic Dermatitis-Like Rash During Evolocumab Treatment of Familial Hypercholesterolemia.
- Published in:
- Journal of Nippon Medical School, 2019, v. 86, n. 3, p. 187, doi. 10.1272/jnms.JNMS.2019_86-309
- By:
- Publication type:
- Article
The effect of dermatophytes on cytokine production by human keratinocytes.
- Published in:
- Archives of Dermatological Research, 2007, v. 299, n. 8, p. 381, doi. 10.1007/s00403-007-0780-7
- By:
- Publication type:
- Article
Effects of D-Phenylalanine- Derivative Hypoglycemic Agent A-4166 on Pancreatic α- and β-Cells: Comparative Study with Glibenclamide.
- Published in:
- Pharmacology, 1995, v. 50, n. 3, p. 175, doi. 10.1159/000139280
- By:
- Publication type:
- Article
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2201, doi. 10.3390/jcm12062201
- By:
- Publication type:
- Article
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1934, doi. 10.3390/jcm12051934
- By:
- Publication type:
- Article
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 974, doi. 10.3390/jcm12030974
- By:
- Publication type:
- Article
The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3880, doi. 10.3390/jcm10173880
- By:
- Publication type:
- Article
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 261, doi. 10.1007/s40261-024-01352-4
- By:
- Publication type:
- Article
Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 861, doi. 10.2147/PPA.S389865
- By:
- Publication type:
- Article
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3201, doi. 10.2147/CCID.S439053
- By:
- Publication type:
- Article